Selective Cytotoxicity and Gene Expression Profiles in Response to Methanolic Extract of Phyllanthus amarus Extract against MCF-7 Breast Cancer Cells

ABSTRACT

Background: Breast cancer, a malignant tumor, is the most common cancer type among women worldwide. Conventional chemotherapy treatments for breast cancer often cause adverse side effects in normal tissues and can lead to treatment failure. Plant-derived natural compounds offer an effective alternative with fewer side effects for cancer patients. Phyllanthus amarus is a medicinal plant widely distributed in China, India, and Brazil and reported to be used for the treatment of various types of cancer. Objectives: This study was aimed to investigate the anticancer efficacy of methanolic extract of P. amarus against MCF-7 breast cancer cells. Materials and Methods: We probed the anticancer activity in MCF-7 breast cancer cells by isolating the methanolic extract of P. amarus leaf extract (MEPA). The standard chemotherapy drug docetaxel is combined with MEPA to increase the drug efficacy. Moreover, the intracellular reactive oxygen species (ROS), alterations in mitochondrial membrane potential (MMP), nuclear condensation, and apoptotic activation were investigated in MCF-7 cells. Additionally, the customized PCR array comprising of cell cycle, apoptosis, mTOR, and JAK-STAT-related genes was studied during different MEPA treatments. Results: In the MCF-7 breast cancer cells, the MEPA and docetaxel combination demonstrated strong cytotoxicity, with IC50 values of 45 and 2.6 µg/mL, respectively. MEPA and docetaxel together exhibited enhanced alterations in MMP and increased generation of ROS in MCF-7 cells. Furthermore, the combination of docetaxel with MEPA induces nuclear condensation and apoptotic cell death. During MEPA treatment, the gene expression profiles in MCF-7 cells were accessed. The JAK-STAT, mTOR signaling pathway, apoptosis, and cell growth-related genes were strongly affected by the dose-dependent administration of MEPA. Conclusion: This study suggests that MEPA could be a useful alternative treatment for breast cancer. When combined with traditional chemotherapy, MEPA might offer better results with fewer side effects. More in vivo studies are needed to confirm MEPA’s effectiveness in animal models.

KEYWORDS

• Apoptosis
• cytotoxicity
• gene expression
• breast cancer
• signaling pathways

Showing references and in-text citations exactly as published.

• DOI10.1177/09731296241285972Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 21, ISSUE 2Pinobanksin Attenuates Cerebral Ischemia– Reperfusion Injury in Rats through Mitigating the Inflammatory ResponsesTianmin Bie, Feng Jia, Yongmei Wang, Zhuoyan Pan · pp. 413–422Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 2Extraction and in vitro and in vivo Antioxidant Activity Evaluation of Polyphenols from Lychee PericarpYing Wang, Hong Deng, Chuqin Yu, Junfeng Ban, Shu Zhang · pp. 423–432Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 2Discussion about the Role of Ghrelin in Myocardial Ischemia/Reperfusion and its Possible MechanismGang Huang, Nan Zheng, Yinqing Huang · pp. 433–442Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 2Sanggenol L Reduces LPS-induced Myocardial Injury and Inflammation by Activating PI3K/ AKT/mTOR and Inhibiting NF-κB in RatsHaojun Wang, Tao Jin, Yuehan Mao, Yi Wei · pp. 443–453Original Research ArticleSame type: Article